The cognitive behavioural prevention of suicide in psychosis: A clinical trial

Abstract Background Suicide behaviour in psychosis is a significant clinical and social problem. There is a dearth of evidence for psychological interventions designed to reduce suicide risk in this population. Aims To evaluate a novel, manualised, cognitive behavioural treatment protocol (CBSPp) ba...

Full description

Saved in:
Bibliographic Details
Published in:Schizophrenia research 2014-07, Vol.156 (2), p.204-210
Main Authors: Tarrier, Nicholas, Kelly, James, Maqsood, Sehar, Snelson, Natasha, Maxwell, Janet, Law, Heather, Dunn, Graham, Gooding, Patricia
Format: Article
Language:English
Subjects:
Adult
Adult and adolescent clinical studies
Behavior therapy. Cognitive therapy
Biological and medical sciences
CBT
Cognitive Behavioral Therapy - methods
Depression
Feasibility Studies
Female
Follow-Up Studies
Humans
Interview, Psychological
Male
Medical sciences
Pilot Projects
Probability
Psychiatry
Psychological intervention
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Psychosis
Psychotic Disorders - psychology
Psychotic Disorders - therapy
Schizophrenia
Self Concept
Self Report
Suicidal Ideation
Suicide
Suicide - prevention & control
Surveys and Questionnaires
Treatment Outcome
Treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Suicide behaviour in psychosis is a significant clinical and social problem. There is a dearth of evidence for psychological interventions designed to reduce suicide risk in this population. Aims To evaluate a novel, manualised, cognitive behavioural treatment protocol (CBSPp) based upon an empirically validated theoretical model. Methods A randomly controlled trial with independent and masked allocated and assessment of CBSPp with TAU (n = 25, 24 sessions) compared to TAU alone (n = 24) using standardised assessments. Measures of suicide probability, and suicidal ideation were the primary outcomes and measures of hopelessness, depression, psychotic symptoms, functioning, and self-esteem were the secondary outcomes, assessed at 4 and 6 months follow-up. Results The CBSPp group improved differentially to the TAU group on two out of three primary outcome measures of suicidal ideation and suicide probability, and on secondary outcomes of hopelessness related to suicide probability, depression, some psychotic symptoms and self-esteem. Conclusions CBSPp is a feasible intervention which has the potential to reduce proxy measures of suicide in psychotic patients.
ISSN:0920-9964
1573-2509
DOI:10.1016/j.schres.2014.04.029